Studies have reported that the mTOR signaling pathway is involved in the pathophysiology of MM [122], and a small mTOR inhibitory molecule (SC06) was found to induce the inhibition of tumor growth in an in vivo model of MM [123]. Here, MTOR is linked to Miyoshi myopathy.